A pharmaceutical industry leader with a legacy of healthcare and wellness dedication spanning over 70 years. With a commanding $13.8 billion market cap as of 2024, the company operates across multiple business verticals including pharmaceuticals, vaccines, specialty drugs, consumer wellness, and animal health. Employing over 25,000+ professionals across all business verticals, the organization focuses on manufacturing operations as its most prominent entity, developing intermediates, formulations, and APIs at state-of-the-art facilities with a commitment to innovation and operational excellence.
Critical surveillance and safety challenges in hazardous chemical operations
I/O Vision: No-code computer vision platform for comprehensive AI-enabled surveillance:
Transformational results across key performance indicators:
Technical implementation and strategic considerations for this deployment